Please use this identifier to cite or link to this item:
http://hdl.handle.net/10261/177463Share/Export:
 SHARE
BASE
|
|
| Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
| Title: | Soluble epoxide hydrolase inhibition as a new therapeutic strategy for the treatment of alzheimer's disease. |
Authors: | Galdeano, Carles; Griñán-Ferré, Christian; Codony, Sandra; Pujol, Eugènia; Yang, Jun; Leiva, Rosana; Escolano, Carmen; Puigoriol-Illamola, Dolors; Companys-Alemany, Júlia; Corpas, Rubén CSIC ORCID; Sanfeliu, Coral CSIC ORCID; Morissea, Christophe; Hammock, Bruce D.; Vázque, Santiago; Pallàs, Mercè | Issue Date: | 3-Sep-2018 | Citation: | XXV EFMC International Symposium on Medicinal Chemistry (2018) | Description: | Trabajo presentado en la XXV EFMC International Symposium on Medicinal Chemistry (European Federation for Medicinal Chemistry), celebrada en Ljubljana, Slovenia, del 2 al 6 de septiembre de 2018 | URI: | http://hdl.handle.net/10261/177463 |
| Appears in Collections: | (IIBB) Comunicaciones congresos |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| accesoRestringido.pdf | 15,38 kB | Adobe PDF |  View/Open |
Review this work
Page view(s)
120
checked on May 23, 2022
Download(s)
31
checked on May 23, 2022
Google ScholarTM
Check
WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.